Plasma Transfusion: Current Evidence, Products, and Clinical Indications
Clarifying "Pure Plasma" Transfusion
The statement "pure plasma has never been used in blood transfusions" is inaccurate. Plasma components are routinely transfused, though terminology matters.
Plasma Products in Clinical Use
| Product | Preparation | Key Components | Primary Indications |
|---|---|---|---|
| Fresh Frozen Plasma (FFP) | Frozen ≤8h post-collection | All coagulation factors, albumin, immunoglobulins | Multiple factor deficiencies, warfarin reversal, TTP, DIC, massive transfusion |
| Plasma Frozen Within 24h (PF24) | Frozen 8–24h post-collection | Similar to FFP; slightly lower Factor VIII | Same as FFP (except Factor VIII deficiency) |
| Thawed Plasma | FFP/PF24 thawed, stored 1–5 days at 1–6°C | Stable factors; declining Factor V, VIII | Massive transfusion protocols, urgent needs |
| Liquid Plasma | Never frozen; stored 1–26 days at 1–6°C | Functional platelets (early), all factors | Pre-hospital, military, massive hemorrhage |
| Pathogen-Reduced Plasma | Amustaline/UVA or riboflavin/UV | Inactivated viruses/bacteria; preserved factors | Equivalent to FFP; enhanced safety |
| Cryoprecipitate | Precipitate from thawed FFP (1–6°C) | Fibrinogen, Factor VIII, vWF, Factor XIII, fibronectin | Hypofibrinogenemia, DIC, uremic bleeding, vWD |
What "Pure Plasma" Might Mean
- Source plasma: Collected by apheresis for fractionation (IVIG, albumin, factor concentrates) — not for direct transfusion
- Recovered plasma: From whole blood donation — processed into FFP/PF24
- Plasma-derived medicinal products (PDMPs): Purified concentrates (Factor VIII, IX, IVIG, albumin) — not "plasma transfusion"
Clinical Decision-Making
- FFP dose: 10–15 mL/kg (typically 4 units adult) to raise factors ~20–30%
- INR correction: FFP rarely normalizes INR unless >2.0; target hemostasis, not number
- Avoid prophylactic FFP for mild coagulopathy without bleeding
- TTP: Plasma exchange (PLEX) with FFP — daily until remission
Risks
- Transfusion-associated circulatory overload (TACO)
- Transfusion-related acute lung injury (TRALI) — mitigated by male-only donors
- Allergic/anaphylactic reactions
- Infectious transmission (extremely low with nucleic acid testing)
Plasma transfusion is evidence-based for specific coagulopathies—not a volume expander or nutritional supplement.
Blood Disorders - Related Articles
- Prolonged Breakthrough Bleeding on Birth Control: Causes and What to Do
- Understanding Circulatory System Diseases: Causes & Conditions
- Understanding High Blood Glucose: Causes, Risks & What to Do
- Understanding Malaria: Symptoms, Causes & Treatment
- Blood Composition: Plasma, Red Cells, White Cells, and Platelets Explained
- Thromboplastin (Tissue Factor): Source, Function, and Clinical Significance
- Understanding Anemia: Symptoms, Causes, and Diagnosis
